Curaleaf Holdings (CURLF) Net Income (2019 - 2026)

Curaleaf Holdings (CURLF) posted quarterly Net Income of -$293000.0 for Q1 2026, up 97.13% year-on-year from -$148636.3 in Q1 2025, and up 98.13% on a QoQ basis from -$15.7 million in Q4 2025.

Curaleaf Holdings (CURLF) Net Income (2019 - 2026) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Net Income for 8 consecutive years, with -$293000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Net Income rose 97.13% year-over-year to -$293000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.1 million (changed 0.31% YoY) and the FY2025 annual result came in at -$26.2 million, down 152.45% from the prior year.
  • Net Income climbed to -$293000.0 in Q1 2026 per CURLF's latest filing, from -$15.7 million in the prior quarter.
  • Over the last five years, Net Income for CURLF reached as high as $144.1 million in Q3 2022 and fell as low as -$8.0 billion in Q4 2023.
  • A 5-year average of -$497.6 million and a median of -$7.9 million in 2023 frame the typical range for Net Income.
  • Annual changes were most pronounced in 2022 — Net Income jumped 241.0% — and 2025, when it slumped 1897.71%.
  • Year by year, Net Income stood at -$481.6 million in 2022, then sank by 1560.08% to -$8.0 billion in 2023, then surged by 99.86% to -$11.3 million in 2024, then plunged by 38.46% to -$15.7 million in 2025, then soared by 98.13% to -$293000.0 in 2026.
  • According to Business Quant data, Net Income over the past three periods registered -$293000.0, -$15.7 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -293,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -293,000.00
Dec 31, 2025 -15.66 Mn
Sep 30, 2025 -2.14 Mn
Jun 30, 2025 -3.00 Mn
Mar 31, 2025 -10.19 Mn
Dec 31, 2024 -11.31 Mn
Sep 30, 2024 1.62 Mn
Jun 30, 2024 -1.28 Mn
Mar 31, 2024 567,000.00
Dec 31, 2023 -8.00 Bn
Sep 30, 2023 -25.92 Mn
Jun 30, 2023 -7.90 Mn
Mar 31, 2023 -12.59 Mn
Dec 31, 2022 -481.60 Mn
Sep 30, 2022 144.08 Mn
Jun 30, 2022 -53.95 Mn
Mar 31, 2022 14.55 Mn
Dec 31, 2021 -135.57 Mn
Sep 30, 2021 -102.18 Mn
Jun 30, 2021 8.29 Mn